{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:05:43Z","timestamp":1777417543830,"version":"3.51.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["P01 HD 065647-01A1"],"award-info":[{"award-number":["P01 HD 065647-01A1"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stanford University, Department of Obstetrics and Gynecology","award":["Division of Maternal-Fetal Medicine"],"award-info":[{"award-number":["Division of Maternal-Fetal Medicine"]}]},{"name":"Stanford University, Department of Obstetrics and Gynecology","award":["Obstetrics Research Funds"],"award-info":[{"award-number":["Obstetrics Research Funds"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["273703678"],"award-info":[{"award-number":["273703678"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["507276351"],"award-info":[{"award-number":["507276351"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015521","name":"Stanford Maternal and Child Health Research Institute","doi-asserted-by":"publisher","award":["Arline"],"award-info":[{"award-number":["Arline"]}],"id":[{"id":"10.13039\/100015521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015521","name":"Stanford Maternal and Child Health Research Institute","doi-asserted-by":"publisher","award":["Pete Harman Faculty Scholar"],"award-info":[{"award-number":["Pete Harman Faculty Scholar"]}],"id":[{"id":"10.13039\/100015521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","award":["H&H Evergreen Faculty Scholar"],"award-info":[{"award-number":["H&H Evergreen Faculty Scholar"]}],"id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005624","name":"Medizinischen Hochschule Hannover","doi-asserted-by":"publisher","award":["Institutional funds"],"award-info":[{"award-number":["Institutional funds"]}],"id":[{"id":"10.13039\/501100005624","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      Observational data suggest that women conceiving without a\n                      <jats:italic>corpus luteum<\/jats:italic>\n                      are at higher risk of developing preeclampsia. While the underlying mechanisms remain unclear, the absence of\n                      <jats:italic>corpus luteum<\/jats:italic>\n                      -derived secretory products may be a contributing factor. This study investigates whether the plasma proteome differs between women who conceive with or without a\n                      <jats:italic>corpus luteum<\/jats:italic>\n                      and examines the relationship with mode of conception.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Plasma samples from 12 participants were collected at three time points: first trimester, third trimester, and postpartum. The cohort included women who conceived unassisted (UC) after infertility, via artificial cycle frozen embryo transfer (AC FET), or natural cycle frozen embryo transfer (NC FET). A total of 36 plasma protein samples were analyzed using mass spectrometry-based proteomics to compare the proteome of women who conceived with and without a\n                      <jats:italic>corpus luteum<\/jats:italic>\n                      , across different conception methods and pregnancy stages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 528 proteins were quantified. No differentially expressed plasma proteins were identified between women with and without a\n                      <jats:italic>corpus luteum<\/jats:italic>\n                      . However, 15 proteins showed differential expression between UC and FET at all time points, with Bonferroni-corrected\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20099.47\u2009\u00d7\u200910\n                      <jats:sup>\u22125<\/jats:sup>\n                      and FC\u2009\u2265\u00a0|2|. Several altered proteins, including PAPPA and ANG, were linked to preeclampsia. SERPINA7 was differentially detected when comparing time points within the unassisted conception method. No significant differences were detected between AC FET and NC FET.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This pilot study revealed a unique proteomic signature associated with the mode of conception. The findings suggest biologically plausible candidate proteins for further testing. Validation in larger cohorts or with alternative proteome analysis technologies is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10815-025-03632-0","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T06:33:14Z","timestamp":1758349994000},"page":"3275-3289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the plasma proteome linked to corpus luteum presence and conception mode across pregnancy stages and postpartum"],"prefix":"10.1007","volume":"42","author":[{"given":"Dhanya","family":"Ramachandran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin Tarek","family":"Dewender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Schr\u00f6der-Heurich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Frob\u00f6se","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Avdulahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia D.","family":"Winn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Pich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-5695","authenticated-orcid":false,"given":"Frauke","family":"von Versen-H\u00f6ynck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"3632_CR1","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1152\/ajpregu.00239.2012","volume":"304","author":"KP Conrad","year":"2013","unstructured":"Conrad KP, Baker VL. Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies. Am J Physiol Regul Integr Comp Physiol. 2013;304:R69-72.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3632_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/01.AOG.0000114989.84822.51","volume":"103","author":"RA Jackson","year":"2004","unstructured":"Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol. 2004;103:551\u201363.","journal-title":"Obstet Gynecol"},{"key":"3632_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/humupd\/dms044","volume":"19","author":"A Pinborg","year":"2013","unstructured":"Pinborg A, Wennerholm UB, Romundstad LB, Loft A, Aittomaki K, S\u00f6derstr\u00f6m-Anttila V, et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update. 2013;19:87\u2013104.","journal-title":"Hum Reprod Update"},{"key":"3632_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/bmj.37957.560278.EE","volume":"328","author":"FM Helmerhorst","year":"2004","unstructured":"Helmerhorst FM, Perquin DAM, Donker D, Keirse MJNC. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ. 2004;328:261.","journal-title":"BMJ"},{"key":"3632_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.fertnstert.2017.08.035","volume":"108","author":"CK Sites","year":"2017","unstructured":"Sites CK, Wilson D, Barsky M, Bernson D, Bernstein IM, Boulet S, et al. Embryo cryopreservation and preeclampsia risk. Fertil Steril. 2017;108:784\u201390.","journal-title":"Fertil Steril"},{"key":"3632_CR6","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/humrep\/dev090","volume":"30","author":"S Opdahl","year":"2015","unstructured":"Opdahl S, Henningsen AA, Tiitinen A, Bergh C, Pinborg A, Romundstad PR, et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod. 2015;30:1724\u201331.","journal-title":"Hum Reprod"},{"key":"3632_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.fertnstert.2020.10.039","volume":"115","author":"LL Asserh\u00f8j","year":"2021","unstructured":"Asserh\u00f8j LL, Spangmose AL, Aaris Henningsen A-K, Clausen TD, Ziebe S, Jensen RB, et al. Adverse obstetric and perinatal outcomes in 1,136 singleton pregnancies conceived after programmed frozen embryo transfer (FET) compared with natural cycle FET. Fertil Steril. 2021;115:947\u201356.","journal-title":"Fertil Steril"},{"key":"3632_CR8","doi-asserted-by":"publisher","first-page":"126.e1","DOI":"10.1016\/j.ajog.2019.03.010","volume":"221","author":"E Ginstr\u00f6m Ernstad","year":"2019","unstructured":"Ginstr\u00f6m Ernstad E, Wennerholm U-B, Khatibi A, Petzold M, Bergh C. Neonatal and maternal outcome after frozen embryo transfer: increased risks in programmed cycles. Am J Obstet Gynecol. 2019;221:126.e1-126.e18.","journal-title":"Am J Obstet Gynecol"},{"key":"3632_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.rbmo.2021.12.004","volume":"44","author":"C Roelens","year":"2022","unstructured":"Roelens C, Racca A, Mackens S, Van Landuyt L, Buelinckx L, Gucciardo L, et al. Artificially prepared vitrified-warmed embryo transfer cycles are associated with an increased risk of pre-eclampsia. Reprod Biomed Online. 2022;44:915\u201322.","journal-title":"Reprod Biomed Online"},{"key":"3632_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.rbmo.2021.01.015","volume":"42","author":"TR Zaat","year":"2021","unstructured":"Zaat TR, Brink AJ, de Bruin J-P, Goddijn M, Broekmans FJM, Cohlen BJ, et al. Increased obstetric and neonatal risks in artificial cycles for frozen embryo transfers? Reprod Biomed Online. 2021;42:919\u201329.","journal-title":"Reprod Biomed Online"},{"key":"3632_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fmed.2020.00104","volume":"7","author":"Z Wang","year":"2020","unstructured":"Wang Z, Liu H, Song H, Li X, Jiang J, Sheng Y, et al. Increased risk of pre-eclampsia after frozen-thawed embryo transfer in programming cycles. Front Med. 2020;7:104.","journal-title":"Front Med"},{"key":"3632_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/HYPERTENSIONAHA.118.12043","volume":"73","author":"F von Versen-H\u00f6ynck","year":"2019","unstructured":"von Versen-H\u00f6ynck F, Schaub AM, Chi Y-Y, Chiu K-H, Liu J, Lingis M, et al. Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019;73:640\u20139.","journal-title":"Hypertension"},{"key":"3632_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/bmj.285.6337.244","volume":"285","author":"A Trounson","year":"1982","unstructured":"Trounson A, Conti A. Research in human in-vitro fertilisation and embryo transfer. Br Med J (Clin Res Ed). 1982;285:244\u20138.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"3632_CR14","doi-asserted-by":"crossref","unstructured":"Ghobara T, Gelbaya TA, Ayeleke RO. Cycle regimens for frozen\u2010thawed embryo transfer. Cochrane Database Syst Rev [Internet]. 2017; Available from: 10.1002\/14651858.CD003414.pub3","DOI":"10.1002\/14651858.CD003414.pub3"},{"key":"3632_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/HYPERTENSIONAHA.119.13015","volume":"74","author":"KP Conrad","year":"2019","unstructured":"Conrad KP, Petersen JW, Chi Y-Y, Zhai X, Li M, Chiu K-H, et al. Maternal cardiovascular dysregulation during early pregnancy after in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019;74:705\u201315.","journal-title":"Hypertension"},{"key":"3632_CR16","doi-asserted-by":"publisher","first-page":"E677","DOI":"10.1152\/ajpendo.00225.2019","volume":"317","author":"KP Conrad","year":"2019","unstructured":"Conrad KP, Graham GM, Chi Y-Y, Zhai X, Li M, Williams RS, et al. Potential influence of the corpus luteum on circulating reproductive and volume regulatory hormones, angiogenic and immunoregulatory factors in pregnant women. Am J Physiol Endocrinol Metab. 2019;317:E677\u201385.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3632_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/1933719118776792","volume":"26","author":"F von Versen-H\u00f6ynck","year":"2019","unstructured":"von Versen-H\u00f6ynck F, Strauch NK, Liu J, Chi Y-Y, Keller-Woods M, Conrad KP, et al. Effect of mode of conception on maternal serum relaxin, creatinine, and sodium concentrations in an infertile population. Reprod Sci. 2019;26:412\u20139.","journal-title":"Reprod Sci"},{"key":"3632_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/humupd\/dmab003","volume":"27","author":"MM Pereira","year":"2021","unstructured":"Pereira MM, Mainigi M, Strauss JF III. Secretory products of the corpus luteum and preeclampsia. Hum Reprod Update. 2021;27:651\u201372. https:\/\/doi.org\/10.1093\/humupd\/dmab003.","journal-title":"Hum Reprod Update"},{"key":"3632_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.119.13779","volume":"75","author":"F von Versen-H\u00f6ynck","year":"2020","unstructured":"von Versen-H\u00f6ynck F, H\u00e4ckl S, Selamet Tierney ES, Conrad KP, Baker VL, Winn VD. Maternal vascular health in pregnancy and postpartum after assisted reproduction. Hypertension. 2020;75:549\u201360.","journal-title":"Hypertension"},{"key":"3632_CR20","doi-asserted-by":"crossref","unstructured":"von Versen-H\u00f6ynck F, Narasimhan P, Selamet Tierney ES, Martinez N, Conrad KP, Baker VL, et al. Absent or excessive corpus luteum number is associated with altered maternal vascular health in early pregnancy. Hypertens (Dallas, Tex 1979). 2019;73:680\u201390.","DOI":"10.1161\/HYPERTENSIONAHA.118.12046"},{"key":"3632_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359\u201362.","journal-title":"Nat Methods"},{"key":"3632_CR22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367\u201372.","journal-title":"Nat Biotechnol"},{"key":"3632_CR23","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res. 2011;10:1794\u2013805.","journal-title":"J Proteome Res"},{"key":"3632_CR24","doi-asserted-by":"publisher","unstructured":"L\u00ea S, Julie J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25:1\u201318.\u00a0https:\/\/doi.org\/10.18637\/jss.v025.i01.","DOI":"10.18637\/jss.v025.i01"},{"key":"3632_CR25","doi-asserted-by":"publisher","unstructured":"Josse J, Husson F. missMDA: a package for handling missing values in multivariate data analysis. J Stat Softw. 2016;70:1\u201331.\u00a0https:\/\/doi.org\/10.18637\/jss.v070.i01.","DOI":"10.18637\/jss.v070.i01"},{"key":"3632_CR26","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/humrep\/deac073","volume":"37","author":"A Busnelli","year":"2022","unstructured":"Busnelli A, Schirripa I, Fedele F, Bulfoni A, Levi-Setti PE. Obstetric and perinatal outcomes following programmed compared to natural frozen-thawed embryo transfer cycles: a systematic review and meta-analysis. Hum Reprod. 2022;37:1619\u201341.","journal-title":"Hum Reprod"},{"key":"3632_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1055\/s-0038-1646453","volume":"66","author":"F Bergmann","year":"1991","unstructured":"Bergmann F, Rotmensch S, Rosenzweig B, How H, Chediak J. The role of von Willebrand factor in pre-eclampsia. Thromb Haemost. 1991;66:525\u20138.","journal-title":"Thromb Haemost"},{"key":"3632_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jtha.2023.10.022","volume":"22","author":"L Neave","year":"2024","unstructured":"Neave L, Thomas M, de Groot R, Doyle AJ, Singh D, Adams G, et al. Alterations in the von Willebrand factor\/ADAMTS-13 axis in preeclampsia. J Thromb Haemost. 2024;22:455\u201365.","journal-title":"J Thromb Haemost"},{"key":"3632_CR29","unstructured":"Ali AI, Nori W, Abdulrahman Hadi BAl. Increased serum amyloid A and C- Reactive Protein in preterm labour women: a case control study. J Pak Med Assoc. 2021;71(Suppl 9):S47\u201350."},{"key":"3632_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1471-0528.1990.tb16247.x","volume":"97","author":"WJ de Villiers","year":"1990","unstructured":"de Villiers WJ, Louw JP, Strachan AF, Etsebeth SM, Shephard EG, de Beer FC. C-reactive protein and serum amyloid A protein in pregnancy and labour. Br J Obstet Gynaecol. 1990;97:725\u201330.","journal-title":"Br J Obstet Gynaecol"},{"key":"3632_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0002-9378(97)80008-7","volume":"176","author":"M Kolben","year":"1997","unstructured":"Kolben M, Bl\u00e4ser J, Ulm K, Schmitt M, Schneider KT, Tschesche H, et al. Angiogenin plasma levels during pregnancy. Am J Obstet Gynecol. 1997;176:37\u201341.","journal-title":"Am J Obstet Gynecol"},{"key":"3632_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13578-023-00991-y","volume":"13","author":"H Wang","year":"2023","unstructured":"Wang H, Zhang Z, Li H, Li J, Li H, Liu M, et al. A cost-effective machine learning-based method for preeclampsia risk assessment and driver genes discovery. Cell Biosci. 2023;13:41.","journal-title":"Cell Biosci"},{"key":"3632_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090881","volume":"9","author":"S Sandri","year":"2014","unstructured":"Sandri S, Urban Borbely A, Fernandes I, de Oliveira EM, Knebel FH, Ruano R, et al. Serum amyloid A in the placenta and its role in trophoblast invasion. PLoS ONE. 2014;9: e90881.","journal-title":"PLoS ONE"},{"key":"3632_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100826","volume":"23","author":"JH Lim","year":"2024","unstructured":"Lim JH, Lim JM, Lee HM, Lee HJ, Kwak DW, Han YJ, et al. Systematic proteome profiling of maternal plasma for development of preeclampsia biomarkers. Mol Cell Proteomics. 2024;23: 100826. https:\/\/doi.org\/10.1016\/j.mcpro.2024.100826.","journal-title":"Mol Cell Proteomics"},{"key":"3632_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065571","volume":"8","author":"Q Wen","year":"2013","unstructured":"Wen Q, Liu LY, Yang T, Alev C, Wu S, Stevenson DK, et al. Peptidomic identification of serum peptides diagnosing preeclampsia. PLoS ONE. 2013;8: e65571.","journal-title":"PLoS ONE"},{"key":"3632_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000214081","volume":"67","author":"K Kristensen","year":"2009","unstructured":"Kristensen K, Wide-Swensson D, Lindstrom V, Schmidt C, Grubb A, Strevens H. Serum amyloid A protein and C-reactive protein in normal pregnancy and preeclampsia. Gynecol Obstet Invest. 2009;67:275\u201380.","journal-title":"Gynecol Obstet Invest"},{"key":"3632_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jog.13532","volume":"44","author":"K Uckan","year":"2018","unstructured":"Uckan K, Sahin HG. Serum amyloid A, procalcitonin, highly sensitive C reactive protein and tumor necrosis factor alpha levels and acute inflammatory response in patients with hemolysis, elevated liver enzymes, low platelet count (HELLP) and eclampsia. J Obstet Gynaecol Res. 2018;44:440\u20137.","journal-title":"J Obstet Gynaecol Res"},{"key":"3632_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/0003319711410308","volume":"63","author":"VJ Karthikeyan","year":"2012","unstructured":"Karthikeyan VJ, Lip GYH, Baghdadi S, Lane DA, Beevers DG, Blann AD. Angiogenin and hemoxygenase in pregnancy: influence of hypertension. Angiology. 2012;63:194\u20138.","journal-title":"Angiology"},{"key":"3632_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12958-021-00742-z","volume":"19","author":"S Zeng","year":"2021","unstructured":"Zeng S, Han M, Jiang M, Liu F, Hu Y, Long Y, et al. Serum complement proteomics reveal biomarkers for hypertension disorder of pregnancy and the potential role of Clusterin. Reprod Biol Endocrinol. 2021;19:56.","journal-title":"Reprod Biol Endocrinol"},{"key":"3632_CR40","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.2147\/DMSO.S309725","volume":"14","author":"C Zhou","year":"2021","unstructured":"Zhou C, Song C, Huang X, Chen S, Long Y, Zeng S, et al. Early prediction model of gestational hypertension by multi-biomarkers before 20 weeks gestation. Diabetes Metab Syndr Obes. 2021;14:2441\u201351.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"3632_CR41","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jamacardio.2023.1312","volume":"8","author":"JS Tyrmi","year":"2023","unstructured":"Tyrmi JS, Kaartokallio T, Lokki AI, J\u00e4\u00e4skel\u00e4inen T, Kortelainen E, Ruotsalainen S, et al. Genetic risk factors associated with preeclampsia and hypertensive disorders of pregnancy. JAMA Cardiol. 2023;8:674\u201383.","journal-title":"JAMA Cardiol"},{"key":"3632_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/B978-0-12-800094-6.00005-4","volume":"63","author":"M Kalousov\u00e1","year":"2014","unstructured":"Kalousov\u00e1 M, Muravsk\u00e1 A, Zima T. Pregnancy-associated plasma protein A (PAPP-A) and preeclampsia. Adv Clin Chem. 2014;63:169\u2013209.","journal-title":"Adv Clin Chem"},{"key":"3632_CR43","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/uog.22093","volume":"56","author":"A Mazer Zumaeta","year":"2020","unstructured":"Mazer Zumaeta A, Wright A, Syngelaki A, Maritsa VA, Da Silva AB, Nicolaides KH. Screening for pre-eclampsia at 11\u201313 weeks\u2019 gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both. Ultrasound Obstet Gynecol. 2020;56:400\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3632_CR44","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1007\/s43032-023-01176-1","volume":"30","author":"M Uriel","year":"2023","unstructured":"Uriel M, Romero Infante XC, Rinc\u00f3n Franco S, Ib\u00e1\u00f1ez Pinilla EA, Rojas NA. Higher PAPP-A values in pregnant women complicated with preeclampsia than with gestational hypertension. Reprod Sci. 2023;30:2503\u201311.","journal-title":"Reprod Sci"},{"key":"3632_CR45","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.placenta.2014.05.012","volume":"35","author":"C Rossmann","year":"2014","unstructured":"Rossmann C, Hammer A, Koyani CN, Kovacevic A, Siwetz M, Desoye G, et al. Expression of serum amyloid A4 in human trophoblast-like choriocarcinoma cell lines and human first trimester\/term trophoblast cells. Placenta. 2014;35:661\u20134.","journal-title":"Placenta"},{"key":"3632_CR46","doi-asserted-by":"publisher","first-page":"1037191","DOI":"10.3389\/fimmu.2022.1037191","volume":"13","author":"C Agostinis","year":"2022","unstructured":"Agostinis C, Zito G, Toffoli M, Peterlunger I, Simoni L, Balduit A, et al. A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia. Front Immunol. 2022;13:1037191.","journal-title":"Front Immunol"},{"key":"3632_CR47","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/aji.12586","volume":"76","author":"C Agostinis","year":"2016","unstructured":"Agostinis C, Stampalija T, Tannetta D, Loganes C, Vecchi Brumatti L, De Seta F, et al. Complement component C1q as potential diagnostic but not predictive marker of preeclampsia. Am J Reprod Immunol. 2016;76:475\u201381.","journal-title":"Am J Reprod Immunol"},{"key":"3632_CR48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.11622\/smedj.2017034","volume":"59","author":"S Luewan","year":"2018","unstructured":"Luewan S, Teja-Intr M, Sirichotiyakul S, Tongsong T. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia. Singapore Med J. 2018;59:55\u20139.","journal-title":"Singapore Med J"},{"key":"3632_CR49","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0014-5793(01)02760-0","volume":"504","author":"LS Laursen","year":"2001","unstructured":"Laursen LS, Overgaard MT, S\u00f8e R, Boldt HB, Sottrup-Jensen L, Giudice LC, et al. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 2001;504:36\u201340.","journal-title":"FEBS Lett"},{"key":"3632_CR50","doi-asserted-by":"crossref","unstructured":"Lin T-M, Halbert SP, Spellacy WN, Berne BH. Plasma concentrations of four pregnancy proteins in complications of pregnancy. Am J Obstet Gynecol [Internet]. 1977;128:808\u201310. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0002937877907256","DOI":"10.1016\/0002-9378(77)90725-6"},{"key":"3632_CR51","doi-asserted-by":"publisher","first-page":"H2399","DOI":"10.1152\/ajpheart.00238.2008","volume":"295","author":"X Wang","year":"2008","unstructured":"Wang X, Chai H, Wang Z, Lin PH, Yao Q, Chen C. Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2008;295:H2399\u2013408.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3632_CR52","doi-asserted-by":"publisher","unstructured":"Pavlov N, Hatzi E, Bassaglia Y, Frendo J-L, Brion DE-, Badet J. Angiogenin distribution in human term placenta, and expression by cultured trophoblastic cells. Angiogenesis [Internet]. 2003;6:317\u201330. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1023\/B:AGEN.0000029412.95244.81","DOI":"10.1023\/B:AGEN.0000029412.95244.81"},{"key":"3632_CR53","doi-asserted-by":"crossref","unstructured":"TELLO\u2010MONTOLIU A, PATEL JV, LIP GYH. Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost [Internet]. 2006;4:1864\u201374. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1538783622181225","DOI":"10.1111\/j.1538-7836.2006.01995.x"},{"key":"3632_CR54","doi-asserted-by":"crossref","unstructured":"Karanam VL, Anim-Nyame N, Page NM. Placental angiogenin inhibitor (ribonuclease inhibitor), a novel gene in pre-eclampsia. Pregnancy Hypertens An Int J Women\u2019s Cardiovasc Heal [Internet]. 2013;3:39\u201343. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2210778912003674","DOI":"10.1016\/j.preghy.2012.10.002"},{"key":"3632_CR55","doi-asserted-by":"publisher","unstructured":"Domingues R, Font P, Sobrinho L, Bugalho MJ. A novel variant in Serpina7 gene in a family with thyroxine-binding globulin deficiency. Endocrine [Internet]. 2009;36:83\u20136. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s12020-009-9202-2","DOI":"10.1007\/s12020-009-9202-2"},{"issue":"Suppl 1","key":"3632_CR56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000182338","volume":"37","author":"T Maruo","year":"1992","unstructured":"Maruo T, Katayama K, Barnea ER, Mochizuki M. A role for thyroid hormone in the induction of ovulation and corpus luteum function. Horm Res. 1992;37(Suppl 1):12\u20138.","journal-title":"Horm Res"},{"key":"3632_CR57","doi-asserted-by":"publisher","unstructured":"Hajifoghaha M, Teshnizi SH, Forouhari S, Dabbaghmanesh MH. Association of thyroid function test abnormalities with preeclampsia: a systematic review and meta-analysis. BMC Endocr Disord [Internet]. 2022;22:240. Available from: https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12902-022-01154-9","DOI":"10.1186\/s12902-022-01154-9"},{"key":"3632_CR58","doi-asserted-by":"crossref","unstructured":"Youssef L, Miranda J, Blasco M, Paules C, Crovetto F, Palomo M, et al. Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics. Sci Rep [Internet]. 2021;11:3048. Available from: https:\/\/www.nature.com\/articles\/s41598-021-82733-z","DOI":"10.1038\/s41598-021-82733-z"},{"key":"3632_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/aji.12162","volume":"71","author":"MC Hoffman","year":"2014","unstructured":"Hoffman MC, Rumer KK, Kramer A, Lynch AM, Winn VD. Maternal and fetal alternative complement pathway activation in early severe preeclampsia. Am J Reprod Immunol. 2014;71:55\u201360.","journal-title":"Am J Reprod Immunol"},{"issue":"354","key":"3632_CR60","first-page":"e1","volume":"199","author":"AM Lynch","year":"2008","unstructured":"Lynch AM, Gibbs RS, Murphy JR, Byers T, Neville MC, Giclas PC, et al. Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol. 2008;199(354):e1-8.","journal-title":"Am J Obstet Gynecol"},{"key":"3632_CR61","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.placenta.2010.03.010","volume":"31","author":"AM Lynch","year":"2010","unstructured":"Lynch AM, Salmon JE. Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta. 2010;31:561\u20137.","journal-title":"Placenta"},{"key":"3632_CR62","doi-asserted-by":"crossref","unstructured":"Degnes M-HL, Westerberg AC, Andresen IJ, Henriksen T, Roland MCP, Zucknick M, et al. Protein biomarker signatures of preeclampsia - a longitudinal 5000-multiplex proteomics study. Sci Rep [Internet]. 2024;14:23654. Available from: https:\/\/www.nature.com\/articles\/s41598-024-73796-9","DOI":"10.1038\/s41598-024-73796-9"},{"key":"3632_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-81277-2","volume":"14","author":"IJ Andresen","year":"2024","unstructured":"Andresen IJ, Zucknick M, Degnes MHL, Angst MS, Aghaeepour N, Romero R, et al. Prediction of late-onset preeclampsia using plasma proteomics: a longitudinal multi-cohort study. Sci Rep. 2024;14:1\u201319.","journal-title":"Sci Rep"},{"key":"3632_CR64","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1530\/rep.0.1220665","volume":"122","author":"JL Pate","year":"2001","unstructured":"Pate JL, Landis Keyes P. Immune cells in the corpus luteum: friends or foes? Reproduction. 2001;122:665\u201376.","journal-title":"Reproduction"},{"key":"3632_CR65","doi-asserted-by":"crossref","unstructured":"Criado-Garc\u00eda O, Fernaud-Espinosa I, Bovolenta P, Sainz de la Cuesta R, Rodr\u00edguez de C\u00f3rdoba S. Expression of the beta-chain of the complement regulator C4b-binding protein in human ovary. Eur J Cell Biol. 1999;78:657\u201364.","DOI":"10.1016\/S0171-9335(99)80051-X"},{"key":"3632_CR66","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/eji.202048658","volume":"51","author":"C Monteiro","year":"2021","unstructured":"Monteiro C, Kasahara T, Sacramento PM, Dias A, Leite S, Silva VG, et al. Human pregnancy levels of estrogen and progesterone contribute to humoral immunity by activating T(FH) \/B cell axis. Eur J Immunol. 2021;51:167\u201379.","journal-title":"Eur J Immunol"},{"key":"3632_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.thromres.2019.03.015","volume":"178","author":"CN Bagot","year":"2019","unstructured":"Bagot CN, Leishman E, Onyiaodike CC, Jordan F, Gibson VB, Freeman DJ. Changes in laboratory markers of thrombotic risk early in the first trimester of pregnancy may be linked to an increase in estradiol and progesterone. Thromb Res. 2019;178:47\u201353.","journal-title":"Thromb Res"},{"key":"3632_CR68","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr424","volume":"39","author":"M Lundberg","year":"2011","unstructured":"Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 2011;39: e102.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03632-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03632-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03632-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:06:54Z","timestamp":1762880814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03632-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3632"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03632-0","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,20]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board at Stanford University (protocol 32773) and by the Ethics Committee at Hannover Medical School (protocol 7715_BO_K_2018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}